Multiple Targets of Toxicity in Environmental Exposure to Low-Dose Cadmium
Overview
Affiliations
Dietary assessment reports and population surveillance programs show that chronic exposure to low levels of environmental cadmium (Cd) is inevitable for most people, and adversely impacts the health of children and adults. Based on a risk assessment model that considers an increase in the excretion of β-microglobulin (βM) above 300 μg/g creatinine to be the "critical" toxicity endpoint, the tolerable intake level of Cd was set at 0.83 µg/kg body weight/day, and a urinary Cd excretion rate of 5.24 µg/g creatinine was considered to be the toxicity threshold level. The aim of this review is to draw attention to the many other toxicity endpoints that are both clinically relevant and more appropriate to derive Cd exposure limits than a βM endpoint. In the present review, we focus on a reduction in the glomerular filtration rate and diminished fecundity because chronic exposure to low-dose Cd, reflected by its excretion levels as low as 0.5 µg/g creatinine, have been associated with dose-dependent increases in risk of these pathological symptoms. Some protective effects of the nutritionally essential elements selenium and zinc are highlighted. Cd-induced mitochondrial dysfunction is discussed as a potential mechanism underlying gonadal toxicities and infertility.
Satarug S Biomolecules. 2025; 15(2).
PMID: 40001486 PMC: 11853145. DOI: 10.3390/biom15020183.
Enhancing renal protection against cadmium toxicity: the role of herbal active ingredients.
Safari Maleki A, Wallace Hayes A, Karimi G Toxicol Res (Camb). 2024; 13(6):tfae222.
PMID: 39712642 PMC: 11662934. DOI: 10.1093/toxres/tfae222.
Zou H, Song J, Luo X, Ali W, Li S, Xiong L Poult Sci. 2024; 104(1):104490.
PMID: 39571196 PMC: 11617461. DOI: 10.1016/j.psj.2024.104490.
Laib I, Ali B, Alsalme A, Cornu D, Bechelany M, Barhoum A Pharmaceuticals (Basel). 2024; 17(8).
PMID: 39204087 PMC: 11357364. DOI: 10.3390/ph17080982.
The Effects of Seleno-Methionine in Cadmium-Challenged Human Primary Chondrocytes.
Urzi Brancati V, Aliquo F, Freni J, Pantano A, Galipo E, Puzzolo D Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065786 PMC: 11280455. DOI: 10.3390/ph17070936.